Prognosis is determined by the stage of the disease. Aggressive therapy is recommended to avoid progressing to end-stage renal disease (ESRD), which is a strong possibility. About 10% of DPGN patients will go into ESRD. If the biopsy shows the presence of crescents, tubule-interstitial injury with inflammation atrophy and fibrosis, the outcome is worse. Other factors that will influence the survival rate are the severity of proteinuria, blood urea nitrogen levels, serum creatine levels, and eGFR. Other bad prognosis features are the presence of hypertension, accelerated hematuria, and hypoalbuminemia. Males are at a higher risk factor than females. Overall, about 50% of patients with DPGN require daily dialysis within 6–12 months after disease presentation. The percentage of glomeruli that show crescents usually correlates to the severity of the renal failure. The survival rate after 5 years is about 30%.
Diffuse proliferative nephritis
Shunt nephritis
Focal proliferative nephritis
Lupus nephritis
Membranous glomerulonephritis
IgA nephropathy
Trench nephritis
Acute proliferative glomerulonephritis